Browse by Journal Title

Article

Cancerostatic octadecylpiperidinoylphosphate liposomes: effect of composition on uptake by and toxicity to J774 mouse macrophage cells and MT1 breast cancer cells in vitro.
Zeisig, R., Stahn, R., Teppke, A.D. and Arndt, D.
Anti-Cancer Drug Design 16 (1): 19-26. 1 January 2001

Role of crown-like side chains in the biological activity of substituted-phenoxazone drugs.
Karawajew, L., Glibin, E.N., Maleev, V.Y., Czerwony, G., Doerken, B., Davies, D.B. and Veselkov, A.N.
Anti-Cancer Drug Design 15 : 331-338. 1 January 2000

Liposome-encapsulated superparamagnetic iron oxide particles as markers in an MRI-guided search for tumor-specific drug carriers.
Paeuser, S., Reszka, R., Wagner, S., Wolf, K.J., Buhr, H.J. and Berger, G.
Anti-Cancer Drug Design 12 : 125-135. 1 January 1997

Interference of new alkylphospholipid analogues with mitogenic signal transduction.
Maly, K., Ueberall, F., Schubert, C., Kindler, E., Stekar, J., Brachwitz, H. and Grunicke, H.
Anti-Cancer Drug Design 10 : 411-425. 1 January 1995

Potential suitability of Na+/K+ -transporting ATPase in pre-screens for anti-cancer agents.
Repke, K.R.H., Schoen, R., Megges, R., Weiland, J., Nissen, E. and Matthes, E.
Anti-Cancer Drug Design 10 : 177-187. 1 January 1995